Clinical trial Recruiting at 2 sites Interventional Ages 60 to 99

Online cognitive behavioral therapy for sleep and mental health in older adults with insomnia

Official title: Improving Sleep to Protect Brain Health in Older Adults: Assessing a Novel Cognitive-behavioral Program for Insomnia Using a Multidomain Web Platform

Run by Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal · NCT06032377 · Data updated 2026-11-12

This study is testing an online therapy program to see if it can help older adults with insomnia improve their sleep and mental health.

More Insomnia trials

Quick facts

Study typeInterventional
Ages60 Years to 99 Years
SexAll
Enrollment275 (estimated)
SponsorCentre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Academic / other
Locations2 sites (Ottawa, Ontario and 1 other locations)
StatusRecruiting
StartedNovember 15, 2023
Main results expectedMay 2026
Study endsDecember 2026
Registry record updatedMarch 18, 2026
Trial IDNCT06032377 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are older adults aged 60 and above who experience insomnia and subjective cognitive complaints.

Probably not a fit

Patients with major neurocognitive disorders, severe hearing or vision impairments, or those currently hospitalized may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates a novel online cognitive-behavioral therapy program designed to improve sleep and mental health in older adults suffering from insomnia and subjective cognitive complaints. Participants will undergo a series of assessments, including phone interviews, video conferences, at-home sleep monitoring, and cognitive testing over a 10-week period. The study aims to compare the effectiveness of the eCBTi+ intervention against a control group, measuring improvements in sleep quality, mental health, and cognitive abilities. Additionally, it will gather normative data by comparing outcomes with good sleepers.

Why it matters

Potential benefit: If successful, this intervention could significantly enhance sleep quality and mental health in older adults, leading to improved cognitive function.

How similar studies have gone: Previous studies have shown promise in using cognitive-behavioral therapy for insomnia, suggesting that this approach may be effective, though the specific online format is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion

* age 60 years or older at the time of enrolment
* Sleep Condition Indicator, SCI ≤ 16 and/or meeting DSM-V criteria based on the symptoms assessed by the SCI
* subjective cognitive complaints (self-report version of Everyday Cognition scale (ECog), score ≥ 2 on any item)
* ability to read and understand French or English
* ability to use a smartphone or tablet, and access to home internet connection
* If on hypnotic or psychotropic medication (including cannabis), being on stable dosage for at least 2 months prior to study entry
* Score on the STOP-BANG questionnaire \< 3 corresponding to participants with low risk of obstructive sleep apnea

Exclusion

* located outside of Québec or Ontario
* current hospitalization or planned major surgery
* uncorrected severe hearing or vision impairment
* reported diagnosis of major neurocognitive disorder or mild cognitive impairment (MCI)
* performance suggestive of major neurocognitive disorder or MCI on T-MoCA \< 17
* reported diagnosis of schizophrenia or bipolar disorder
* reported diagnosis or positive screen on the MINI for psychotic or bipolar disorders
* high suicidal risk, as assessed by the modified Columbia-Suicide Severity Rating Scale
* reported diagnosis or positive screening (apnea-hypopnea index \>30 on a level 3 home sleep apnea test) for another untreated sleep disorder (e.g., sleep disordered breathing (OSA), REM sleep behavior disorder (RBD), restless legs syndrome (RLS); individuals with treated and controlled OSA (residual apnea-hypopnea index \<30 and good therapeutic compliance) or RLS will not be excluded
* current shift work
* currently receiving CBT, having received CBTi in the past
* frequent alcohol consumption having an impact on functionning (\>10 glasses/week and having a significant impact on functionning)
* illicit drugs use (more than once a month)

Additional exclusion criteria for neuroimaging

* psychotropic (including hypnotic) medication in the past 2 weeks
* contraindications for MRI (e.g., pacemaker, metallic implant, claustrophobia)
* unable or unwilling to come to one of the participating MRI centers (Montreal, Ottawa)
* medical conditions likely to affect sleep; in particular:
* current neurological disorder (e.g., epilepsy with any seizure in the past year, concussion in the past 3 months, multiple sclerosis, Parkinson's disease)
* past history of brain lesion (e.g., brain hemorrhage, brain tumor, any condition having required brain surgery)
* major surgery (i.e., requiring general anesthesia) in the past 3 months
* untreated thyroid disorder
* chronic pain syndrome self-reported as interfering with sleep (e.g., migraine, fibromyalgia, rheumatoid arthritis)
* recent and severe infection in the past 3 months (e.g., pneumonia, kidney infection)
* active cancer or treated cancer with post-cancer treatment for less than 2 years

Inclusion/exclusion criteria for good sleepers Twenty-five good sleepers without cognitive complaint will be recruited as controls for the MRI session following the same criteria described above, except that SCI ≥ 17, not meeting the diagnostic criteria for chronic insomnia as assessed by the insomnia module of the SCID and no subjective cognitive complaint.

Where it's running

  • The Royal's Institute of Mental Health Research (IMHR)
    Ottawa, Ontario, Canada
    Recruiting
  • Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de l'Île-de-Montréal. CCSMTL - IUGM
    Montreal, Quebec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.